Publication: 3996

Publication: 3996

HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 42 (16) 1890-1902

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: Alliance-data-source,-external-user
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 13

Parents:: 3259
Children:: None

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:

Pharmas:: BMS (now Lilly), Genentech, Pfizer, Sanofi
Grants:: U10CA180821, U10CA180882; UG1CA233253, UG1CA233180, UG1CA233337, UG1CA233373; U10CA180888, UG1CA180830 (SWOG).

Corr. Author:
Authors:: Francesca Battaglin Fang-Shu Ou Xueping Qu Howard S. Hochster Donna Niedzwiecki Richard M. Goldberg Robert J. Mayer Karam Ashouri Tyler J. Zemla Charles D. Blanke Alan P. Venook Omar Kabbarah Heinz-Josef Lenz Federico Innocenti

Networks:: CA011, CA824, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013

Study: Alliance-A152001
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80405
Phases:: N/A, 3

Keywords:: Article